Patents by Inventor Michel Franz

Michel Franz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7303761
    Abstract: The present invention is related to a solid pharmaceutical composition comprising two separate regions, a first region comprising at least one non-steroidal anti-inflammatory drug (NSAID) and an adequate pharmaceutical carrier containing a retardant material for an extended release delivery of said non-steroidal anti-inflammatory drug (NSAID), and a second region comprising a stabilized gastroprotective prostaglandin and an adequate pharmaceutical carrier for an immediate release of said stabilized gastroprotective prostaglandin.
    Type: Grant
    Filed: February 26, 2004
    Date of Patent: December 4, 2007
    Assignee: SPRL FRANPharma
    Inventor: Michel Franz
  • Publication number: 20040185100
    Abstract: The present invention is related to a solid pharmaceutical composition comprising two separate regions,
    Type: Application
    Filed: February 26, 2004
    Publication date: September 23, 2004
    Applicant: SPRL FRANpharma
    Inventor: Michel Franz
  • Patent number: 5015481
    Abstract: A stabilized pharmaceutical composition which is an admixture of an NSAID selected from diclofenac and piroxicam, a prostaglandin and hydroxypropyl methylcellulose for maintaining the prostaglandin in a therapeutically effective amount without negatively affecting the therapeutic activity of the NSAID.
    Type: Grant
    Filed: May 3, 1990
    Date of Patent: May 14, 1991
    Assignee: G. D. Searle & Co.
    Inventors: Michel Franz, Michel Jans, Leo K. Mathur, Kamlesh B. Shah, James E. Truelove
  • Patent number: 4285964
    Abstract: A salt of (+)-catechin formed of the reaction product of (+)-catechin with at least a basic amino-acid, such as L-lysine and L-arginine; a hydrosoluble double salt is formed by the reaction product of (+)-catechin with a basic amino-acid, such as L-lysine and L-arginine, and another inorganic or organic acid.
    Type: Grant
    Filed: August 30, 1979
    Date of Patent: August 25, 1981
    Assignee: Continental Pharma
    Inventors: Paul Niebes, Andras Vincze, Joseph Roba, Georges Lambelin, Daniel Matagne, Etienne Hanon, Michel Franz